Federated Hermes’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.1M | Hold |
|
|||||
|
2025
Q1 | $49.7M | Hold |
|
|||||
|
2024
Q4 | $79.7M | Hold |
|
|||||
|
2024
Q3 | $109M | Hold |
|
|||||
|
2024
Q2 | $114M | Sell |
|
|||||
|
2024
Q1 | $159M | Sell |
|
|||||
|
2023
Q4 | $149M | Hold |
|
|||||
|
2023
Q3 | $120M | Sell |
|
|||||
|
2023
Q2 | $137M | Hold |
|
|||||
|
2023
Q1 | $115M | Buy |
|
|||||
|
2022
Q4 | $71.9M | Buy |
|
|||||
|
2022
Q3 | $52.9M | Buy |
|
|||||
|
2022
Q2 | $56.1M | Sell |
|
|||||
|
2022
Q1 | $101M | Buy |
|
|||||
|
2021
Q4 | $137M | Buy |
|
|||||
|
2021
Q3 | $146M | Buy |
|
|||||
|
2021
Q2 | $102M | Sell |
|
|||||
|
2021
Q1 | $132M | Sell |
|
|||||
|
2020
Q4 | $150M | Buy |
|
|||||
|
2020
Q3 | $59.1M | Buy |
|
|||||
|
2020
Q2 | $28.7M | Buy |
|